CD8A and lung carcinoma: First, we selected the five most expanded clonotypes (534, 232, 169, 101, and 92 cells, respectively; Table S4) among tumor-infiltrating CD8+ T cells as initial candidates, since highly frequent clonotypes are often enriched for neoantigen-specific T cells in lung cancers [32].